Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-13

Clinical Trial Update: Aromatherapy Inhaler Use for HSCT Distress [NA]

View source ↗

Summary

Stanford University sponsors a clinical trial evaluating an aromatherapy inhaler to reduce distress in patients undergoing hematopoietic stem cell transplantati…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Aromatherapy inhaler

Snippet

Sponsor: Stanford University | Conditions: Cancer Distress, Cancer Coping | NA | Status: RECRUITING